S&P affirms Yestar Healthcare

S&P said it affirmed its BB- long-term issuer credit rating on Yestar Healthcare Holdings Co. Ltd., a distributor of in-vitro-diagnostic (IVD) products and photographic films.

The outlook is stable.

“We affirmed the rating because we expect Yestar to maintain its credit metrics over the next 12-24 months and continue to deleverage while expanding its earnings through both organic and inorganic growth, particularly in the IVD distribution business,” S&P said in a news release.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.